| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $961K | — | -27.2% |
| R&D Expense | $3.3M | — | +77.5% |
| SG&A Expense | $1.2M | — | -16.1% |
| Operating Income | -$3.6M | — | -81.1% |
| Interest Expense | $834 | — | -8.3% |
| Net Income | -$3.6M | — | -82.8% |
| EPS (Basic) | -$0.52 | — | +62.6% |
| EPS (Diluted) | -$0.52 | — | +62.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $745K | -82.7% | -75.6% |
| Current Assets | $2.0M | -72.3% | -54.4% |
| Total Assets | $2.2M | -70.9% | -53.0% |
| Current Liabilities | $2.8M | -37.9% | +61.1% |
| Total Liabilities | $2.8M | -37.9% | +50.0% |
| Stockholders' Equity | -$340K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | -105.0% |
| Financing Cash Flow | -$64K | — | -105.1% |
| -111.2% |